Sort   by:  
 Page size 
UnknownScriptaid is a prospective agent for improving human asthenozoospermic sample quality and fertilization rate in vitro.
Not available
S-EPMC11449406 | biostudies-literature
UnknownClinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study.
Not available
S-EPMC10389616 | biostudies-literature
UnknownComprehensive metabolomics expands precision medicine for triple-negative breast cancer.
Not available
S-EPMC9061756 | biostudies-literature
ProteomicsEstrogen Receptor Mutant Coregulator
Biotinylated 4xERE-containing DNA immobilized on streptavidin beads used to pulldown proteins recruited by unliganded WT ER-alpha versus Y537S, D538G, or ESR1-YAP1 fusion proteins from HeLa S3 human cell nuclear extracts.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-02-08 | MSV000080536 | MassIVE
UnknownLILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis.
Not available
S-EPMC10363120 | biostudies-literature
ProteomicsProteome of Chinese Breast Cancers (FUSCC-Shao Lab)
Raw data of TMT-labeled proteome of Chinese breast cancers. Uploaded by Zhi-Ming Shao Lab, Fudan University Shanghai Cancer Center (FUSCC)
ORGANISM(S): Homo Sapiens 
2023-06-11 | PXD042886 |
UnknownSitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).
Not available
S-EPMC12831270 | biostudies-literature
UnknownGenomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Not available
S-EPMC8575965 | biostudies-literature
UnknownFamitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Not available
S-EPMC9365373 | biostudies-literature
UnknownMetabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis.
Not available
S-EPMC12811260 | biostudies-literature
Sort   by:  
 Page size